188 related articles for article (PubMed ID: 11475580)
1. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia.
Arai Y; Obinata K; Sato Y; Hisata K; Tadokoro R; Tawa T; Kinoshita K
Eur J Pediatr; 2001 Jul; 160(7):425-9. PubMed ID: 11475580
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
3. Serum KL-6 levels in pediatric patients: reference values for children and levels in pneumonia, asthma, and measles patients.
Imai T; Takase M; Takeda S; Kougo T
Pediatr Pulmonol; 2002 Feb; 33(2):135-41. PubMed ID: 11802251
[TBL] [Abstract][Full Text] [Related]
4. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
6. [Lung injury and serum markers].
Suwabe A
Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
8. Elevated KL-6 levels in fatal measles pneumonia.
Narita M; Nakayama M; Yamada S; Togashi T
Eur J Pediatr; 2001 Jul; 160(7):454-5. PubMed ID: 11475589
[TBL] [Abstract][Full Text] [Related]
9. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of KL-6 reflect disease activity of interstitial pneumonia associated with ANCA-related vasculitis.
Iwata Y; Wada T; Furuichi K; Kitagawa K; Kokubo S; Kobayashi M; Sakai N; Yoshimoto K; Shimizu M; Kobayashi K; Yokoyama H
Intern Med; 2001 Nov; 40(11):1093-7. PubMed ID: 11757762
[TBL] [Abstract][Full Text] [Related]
11. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
13. [New serum markers to monitor treatment of acute exacerbation of interstitial lung disease].
Otsuka M; Takahashi H; Fujisima T; Nishiyama K; Kon H; Outi H; Imai Y; Sakon O; Shiratori M; Abe S
Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):298-302. PubMed ID: 11481832
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.
Kuwano K; Maeyama T; Inoshima I; Ninomiya K; Hagimoto N; Yoshimi M; Fujita M; Nakamura N; Shirakawa K; Hara N
Respirology; 2002 Mar; 7(1):15-21. PubMed ID: 11896896
[TBL] [Abstract][Full Text] [Related]
16. SP-D as a marker of amiodarone-induced pulmonary toxicity.
Umetani K; Abe M; Kawabata K; Iida T; Kohno I; Sawanobori T; Kugiyama K
Intern Med; 2002 Sep; 41(9):709-12. PubMed ID: 12322797
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
[TBL] [Abstract][Full Text] [Related]
18. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease.
Suzuki K; Takada H; Oka S; Kanouzawa S; Iimuro M; Kitazumi Y; Arima T; Ohyama R; Kuwayama H
Intern Med; 2003 Aug; 42(8):650-4. PubMed ID: 12924486
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
